Lumexa Imaging (LMRI) closed at $10.71 on Oct 6, 2026, down 0.6% on the day. The stock is down 12.1% over the past month, down 11.9% over three months and down 42.1% year to date. It trades 44.9% below its 52-week high of $19.45 and 66.0% above its 52-week low of $6.45. The close sits below its 50-day moving average ($11.26) and below its 200-day moving average ($11.68).
LMRI is scheduled to report earnings on Nov 10, 2026.
Lumexa Imaging is scheduled to report on Nov 10, 2026.
No — the Oct 6, 2026 close of $10.71 is 8.3% below the 200-day average of $11.68.
LMRI closed 44.9% below its 52-week high of $19.45.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
